These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3125744)

  • 41. [Treatment of persistent corneal epithelial disorders with human plasma fibronectin eyedrops].
    Qu XA
    Zhonghua Yan Ke Za Zhi; 1990 Jan; 26(1):21-3. PubMed ID: 2373030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.
    Yasuda H; Sonobe M; Yamashita M; Terada M; Hatanaka I; Huitian Z; Shigeta Y
    Diabetes; 1989 Jul; 38(7):832-8. PubMed ID: 2525492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Aldose reductase inhibitors in diabetic neuropathy].
    Erkelens DW; Bravenboer B
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):775-6. PubMed ID: 2110629
    [No Abstract]   [Full Text] [Related]  

  • 44. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The cornea: stasis and dynamics].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aldose reductase inhibition and the phosphorus-31 profile of the intact diabetic rat lens.
    Tsubota K; Yoshida M; Toda T; Ono M; Kajiwara K; Cheng HM
    Ophthalmic Res; 1993; 25(6):393-9. PubMed ID: 8309679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of aldose reductase in the development of diabetes-associated complications.
    Kador PF; Kinoshita JH
    Am J Med; 1985 Nov; 79(5A):8-12. PubMed ID: 3934965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldose reductase inhibition for diabetic neuropathy.
    Lancet; 1983 Oct; 2(8356):969. PubMed ID: 6138528
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications.
    Varma SD
    Prog Clin Biol Res; 1986; 213():343-58. PubMed ID: 3086893
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical trial of an aldose reductase inhibitor in diabetic neuropathy.
    Handelsman DJ; Turtle JR
    Diabetes; 1981 Jun; 30(6):459-64. PubMed ID: 6785131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
    Ohrloff C; Hockwin O; Korte I; Wegener A
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
    Akagi Y; Terubayashi H; Ikebe H; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
    MacGregor LC; Matschinsky FM
    J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [2,2',4,4'-tetrahydroxybenzophenone as a new aldose reductase inhibitor (author's transl)].
    Ono H; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(4):353-7. PubMed ID: 6810663
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhibition studies on chicken muscle aldose reductase.
    Murphy DG; Davidson WS
    Biochem Pharmacol; 1985 Aug; 34(16):2961-5. PubMed ID: 3927923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.